Review of: "Efficacy, safety, and lot to lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): a double-blind, randomised, controlled phase 3 trial"
- Arindam Basu
No endorsements
This article has not been endorsed yet.
Like this work?
Let others know. Sign in to add your endorsement.